Name
RF2-04: Effect of adjuvant carboplatin intensified chemotherapy versus standard chemotherapy on survival in women with high-risk early-stage triple-negative breast cancer (CITRINE): a phase 3 randomized trial Commentary by: Joseph Sparano, MD, FACP
Date & Time
Monday, December 1, 2025
Speakers
Virtual Session Link
Total Minutes
04:59
OnDemand Video URL